YAP1 and esophageal squamous cell carcinoma: We found that in patients with nonsurgical esophageal squamous cell carcinoma, YAP1 amplification is an adverse prognostic factor associated with significantly shorter local recurrent‐free survival (LRFS) after definitive chemoradiotherapy.